comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 20:06:24 - browse：498

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

WSS

Bird flu surveillance in wastewater gets boost from consortium

Biogen joins immunology wave with $1.15 billion acquisition of HI

UnitedHealth argues against case alleging wrongful AI care denials

Reports of telehealth's death have been greatly exaggerated

More regulation could be coming for drug ads

Reports of telehealth's death have been greatly exaggerated

hotspot

comprehensive

Wikipedia

Supreme Court strikes down use of affirmative action

Bird flu surveillance in wastewater gets boost from consortium

Anesthesiologist group: stop taking Ozempic before surgery

Cue Health, Covid

How one medical school became remarkably diverse

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

At least 13 dead in Texas as scorching temps continue

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Trump demands the U.S. pay no more for drugs than other countries … again

Discs beat pads, tampons for heavy menstrual flow, new study shows

knowledge

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

H5N1 bird flu outbreak: Second human case reported, in Michigan

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Bird flu surveillance in wastewater gets boost from consortium

Germany receives 178 compensation applications from gay servicepeople over discrimination

knowledge

hotspot

focus

entertainment